Print Page

Sandhoff Disease: General Information

- Content Writer/Editor for Disabled World
Published: 2009/04/05 - Updated: 2023/02/01
Topic: Pediatric Health Concerns (Publications Database)

Page Content: Synopsis Introduction Main Item

Synopsis: Sandhoff disease is a rare genetic lipid storage disorder resulting in the progressive deterioration of the central nervous system.

Sandhoff disease is caused by a mutation (defect) in the HEXB gene.

This defect causes a deficiency of the enzyme beta-hexosaminidase, which results in the accumulation of certain fats (lipids) in the brain and other organs of the body.

Introduction

Sandhoff Disease Alternate Names: Gangliosidosis GM2 type II, Gangliosidosis Beta Hexosaminidase B Deficiency, Hexosaminidases A and B Deficiency.

The U.S. Social Security Administration (SSA) has included Sandhoff Disease as a Compassionate Allowance to expedite a disability claim.

Main Item

Sandhoff disease is caused by a mutation (defect) in the HEXB gene. This defect causes a deficiency of the enzyme beta-hexosaminidase, which results in the accumulation of certain fats (lipids) in the brain and other organs of the body.

Infantile Form

Onset of the disorder usually occurs at six months of age. Infants with Sandhoff disease typically appear normal until 3 to 6 months, when development slows and muscles used for movement weaken. Sandhoff disease symptoms may include:

Onset by six months of age and positive gene testing confirm the diagnosis of this disease. Individuals and carriers of Sandhoff disease can be identified by a simple blood enzyme analysis test that measures HEXB activity.

Treatment

There is no specific treatment for Sandhoff disease.

Supportive treatment includes proper nutrition, hydration, and keeping the airway open. Anticonvulsants may initially control seizures. In other ongoing studies, many children have received experimental treatment using stem cell transplants from umbilical cord blood. Although these limited trials have not yet produced a treatment or cure, scientists continue to study these and other investigational approaches.

Prognosis

The prognosis for individuals with Sandhoff disease is poor. In the Infantile form, affected children usually do not survive past age 3, and respiratory infections generally cause death.

Explore Similar Topics

1 - - Comparing the effects of the transport response, the relaxed reaction while being carried, with motionless maternal holding or rocking and examining if the effects persist with longer carrying in infants.

2 - - University of California Riverside researchers examine how expectation of pain influences pain experience in children.

3 - - By analyzing most common genetic variants scientists aim at improving diagnosis and treatment for nephrotic syndrome which presents high resistance to drugs and relapse in post-transplant scenario.

Complete Publications Database


Page Information, Citing and Disclaimer

Disabled World is a comprehensive online resource that provides information and news related to disabilities, assistive technologies, and accessibility issues. Founded in 2004 our website covers a wide range of topics, including disability rights, healthcare, education, employment, and independent living, with the goal of supporting the disability community and their families.

Cite This Page (APA): Langtree, I. C. (2009, April 5 - Last revised: 2023, February 1). Sandhoff Disease: General Information. Disabled World. Retrieved December 1, 2024 from www.disabled-world.com/health/pediatric/sandhoff-disease.php

Permalink: <a href="https://www.disabled-world.com/health/pediatric/sandhoff-disease.php">Sandhoff Disease: General Information</a>: Sandhoff disease is a rare genetic lipid storage disorder resulting in the progressive deterioration of the central nervous system.

While we strive to provide accurate and up-to-date information, it's important to note that our content is for general informational purposes only. We always recommend consulting qualified healthcare professionals for personalized medical advice. Any 3rd party offering or advertising does not constitute an endorsement.